Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,860 | 1 | 64.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,375 | 2 | 18.3% |
| Food and Beverage | $1,278 | 16 | 17.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,860 | 1 | $0 (2023) |
| Circassia Pharmaceuticals Inc | $1,602 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $368.81 | 4 | $0 (2023) |
| Optinose US, Inc. | $288.72 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $267.83 | 4 | $0 (2017) |
| ALK-Abello, Inc | $106.12 | 1 | $0 (2022) |
| Ambu Inc. | $19.03 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131.11 | 1 | Optinose US, Inc. ($131.11) |
| 2023 | $5,087 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,860) |
| 2022 | $106.12 | 1 | ALK-Abello, Inc ($106.12) |
| 2021 | $234.42 | 2 | AstraZeneca Pharmaceuticals LP ($234.42) |
| 2020 | $19.03 | 1 | Ambu Inc. ($19.03) |
| 2019 | $50.66 | 1 | OptiNose US, Inc. ($50.66) |
| 2018 | $139.04 | 2 | Circassia Pharmaceuticals Inc ($125.00) |
| 2017 | $1,745 | 8 | Circassia Pharmaceuticals Inc ($1,477) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $131.11 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $4,860.00 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $120.35 | General |
| Category: Respiratory | ||||||
| 06/06/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $106.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/15/2022 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $106.12 | General |
| Category: Allergy and Immunology | ||||||
| 12/08/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $109.66 | General |
| Category: Respiratory | ||||||
| 05/19/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Respiratory | ||||||
| 10/29/2020 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $19.03 | General |
| 09/18/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $50.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/18/2018 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 04/04/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 12/19/2017 | Teva Pharmaceuticals USA, Inc. | AIRDUO (Drug) | Food and Beverage | In-kind items and services | $120.91 | General |
| Category: Respiratory | ||||||
| 09/28/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Respiratory | ||||||
| 09/27/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $100.23 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 06/28/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 05/23/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: Respiratory | ||||||
| 04/19/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 04/05/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 03/14/2017 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Drug) | Food and Beverage | In-kind items and services | $138.72 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 25 | 40 | $1,209 | $358.41 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 12 | 23 | $529.00 | $216.45 | 40.9% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 13 | 17 | $680.00 | $141.96 | 20.9% |
About Dr. Gary Kohn, MD
Dr. Gary Kohn, MD is a Pediatric Pulmonology healthcare provider based in Berkeley Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710954409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Kohn, MD has received a total of $7,513 in payments from pharmaceutical and medical device companies, with $131.11 received in 2024. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($4,860).
As a Medicare-enrolled provider, Kohn has provided services to 25 Medicare beneficiaries, totaling 40 services with total Medicare billing of $358.41. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Pediatric Pulmonology
- Location Berkeley Heights, NJ
- Active Since 03/02/2006
- Last Updated 07/22/2019
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1710954409
Products in Payments
- OFEV (Drug) $4,860
- NIOX VERO DEVICE (Device) $1,602
- Xhance (Drug) $288.72
- FASENRA (Biological) $234.42
- CINQAIR (Drug) $138.72
- AIRDUO (Drug) $120.91
- TEZSPIRE (Biological) $120.35
- Odactra (Drug) $106.12
- FASENRA (Drug) $14.04
- QVAR (Drug) $8.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.